NantHealth, Inc. (NHIQ)
OTCMKTS: NHIQ · Delayed Price · USD
1.330
+0.080 (6.40%)
May 2, 2024, 10:40 AM EDT - Market open
NantHealth Revenue
NantHealth had revenue of $64.27M in the twelve months ending September 30, 2023, down -1.93% year-over-year. Revenue in the quarter ending September 30, 2023 was $12.47M, a -25.04% decrease year-over-year. In the year 2022, NantHealth had annual revenue of $67.00M with 6.95% growth.
Revenue (ttm)
$64.27M
Revenue Growth
-1.93%
P/S Ratio
0.53
Revenue / Employee
$176,088
Employees
365
Market Cap
36.54M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 67.00M | 4.35M | 6.95% |
Dec 31, 2021 | 62.65M | -10.52M | -14.38% |
Dec 31, 2020 | 73.17M | -4.26M | -5.50% |
Dec 31, 2019 | 77.43M | -12.04M | -13.45% |
Dec 31, 2018 | 89.46M | 2.79M | 3.22% |
Dec 31, 2017 | 86.68M | 6.27M | 7.80% |
Dec 31, 2016 | 80.40M | 34.23M | 74.12% |
Dec 31, 2015 | 46.18M | 12.26M | 36.13% |
Dec 31, 2014 | 33.92M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
NHIQ News
- 9 days ago - NantHealth Welcomes Marc Harrison as Chief Legal Officer to Executive Team - Business Wire
- 22 days ago - NantHealth Strengthens Product Leadership Team to Drive Innovation in Healthcare Technology - Business Wire
- 1 year ago - NantHealth's Eviti Connect Achieves HITRUST Risk-based, 2-year Certification to Further Mitigate Risk in Third-Party Privacy, Security and Compliance - Business Wire
- 1 year ago - NantHealth Announces $22.5 Million New Financing with Highbridge and Nant Capital - Business Wire
- 1 year ago - OpenNMS releases OpenNMS Meridian 2023 with New Cloud-enabled Capabilities - Business Wire
- 1 year ago - NantHealth Announces 1-for-15 Reverse Stock Split - Business Wire
- 1 year ago - NantHealth Reports 2022 Third Quarter Financial Results - Business Wire
- 1 year ago - NantHealth to Report 2022 Third-Quarter Financial Results and Host Conference Call on Thursday, November 3 - Business Wire